PO.5.99 Drug repurposing for treating lupus nephritis based on transcriptome profiling and autoimmunity-related serological markers
Crossref DOI link: https://doi.org/10.1136/lupus-2022-elm2022.124
Published Online: 2022-09-27
Published Print: 2022-10
Update policy: https://doi.org/10.1136/crossmarkpolicy
Parodis, I
Lindblom, J
Toro-Domínguez, D
Carnero-Montoro, E
Borghi, MO
Castillo, J
Enman, Y
Repsilber, D
Mohan, C
Alarcón-Riquelme, M
Barturen, G
License valid from 2022-09-27